Lisa Schots
- ORCID iD
-
0000-0003-3375-7467
Show
Sort by
-
- Journal Article
- A1
- open access
Exposure-response relationship of guselkumab and the potential of serum proteomics in identifying predictive biomarker candidates in psoriasis
-
- Journal Article
- A2
- open access
Ixekizumab trough concentrations in psoriasis : paving the way towards personalised therapy : a cohort study
-
- PhD Thesis
- open access
Optimizing the use of biologics in psoriasis : role of therapeutic drug monitoring and serum biomarkers
(2024) -
- Miscellaneous
- open access
GDF15 mediates inflammation-associated bone loss through a brain-bone axis
-
- Journal Article
- A1
- open access
Blocking interleukin-17 in psoriasis : real-world experience from the PsoPlus cohort
-
- Journal Article
- A1
- open access
Therapeutic drug monitoring in dermatology : the way towards dose optimization of secukinumab in chronic plaque psoriasis
-
Dermatologists on the medical need for therapeutic drug monitoring of biologics in psoriasis : results of a structured survey
-
- Journal Article
- A1
- open access
Dose reduction of the new generation biologics (IL-17 and IL-23 inhibitors) in psoriasis : study protocol for an international, pragmatic, multicenter, randomized, controlled, non-inferiority study : the BeNeBio study
-
- Conference Paper
- C3
- open access
No relationship between total kindey volume class or genotype and 24h blood pressure control in adult ADPKD patients